Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

1️⃣ ‘Summer of hell’: What’s typically a key money-making time for airlines could fall short this year. Fears about flying, ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

Here are five reasons to feel good about eating dark chocolate (anything 70 per cent cocoa or higher) regularly. Cocoa – the ...

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the ...

A government crackdown on cheaper copies of Ozempic and similar diabetes and ... Patients originally turned to these less-expensive alternatives not approved by the Food and Drug Administration ...

Novo Nordisk has ousted chief executive Lars Fruergaard Jørgensen as the maker of pioneering obesity drug Ozempic battles a slump in profit growth, declining market share and a plunging stock price.